Publications by authors named "Carl Davis"

Claim this Profile
I
Influenza vaccine based on AS03-adjuvanted chimeric HA induces long-lived stalk-specific plasma cells in bone marrow and lymph nodes of nonhuman primates.
Akil Akhtar, Tiffany M Styles, Chunyang Gu, André Nicolás León, Gregory K Tharp, Carl W Davis

Nat Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 expression identifies proliferating malignant CLL B cells and is a potential biomarker of response to BTK inhibitor therapy.
Andres Chang, Adam N Pelletier, Donald J McGuire, Maria Tsagiopoulou, Maria Karipidou, Carl Davis

Proc Natl Acad Sci U S A· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monotherapy with antibody 1C3 partially protects Ebola virus-exposed macaques.
Gabriella Worwa, Carl W Davis, Sarah E Klim, Jacquelyn Turcinovic, Krystle N Agans

J Virol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP in a position elevated from the virion membrane.
Kathryn M Hastie, Zhe Li Salie, Zunlong Ke, Peter J Halfmann, Lisa Evans DeWald, Carl W Davis

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of PF-07265028, A Selective Small Molecule Inhibitor of Hematopoietic Progenitor Kinase 1 (HPK1) for the Treatment of Cancer.
Rebecca A Gallego, Sujin Cho-Schultz, Matthew Del Bel, Anne-Marie Dechert-Schmitt, Joyann S Donaldson, Carl Davis

J Med Chem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Highly Selective Inhibitors of Microtubule-Associated Serine/Threonine Kinase-like (MASTL).
Rebecca A Gallego, Stephanie Scales, Chad Toledo, Marin Auth, Louise Bernier, Carl Davis

J Med Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Airway Outcomes and Interventions in Children With Oesophageal Atresia With Tracheoesophageal Fistula: A 20-year Single Centre Observational Study.
Sandra E Davis, Carl Davis, Neil Patel, Haytham Kubba, W Andrew Clement

J Pediatr Surg· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome sequence and annotation of sp. strain YE332, isolated from a cattle rumen fermentation of Leucaena leaf.
Rosalind Gilbert, Carl Davis, Jenny Gravel, Diane Ouwerkerk

Microbiol Resour Announc· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Tumor Binding Across Tumor Types and Cell Lines to Support Free Drug Considerations for Oncology Drug Discovery.
Samantha Jordan, Sangwoo Ryu, Woodrow Burchett, Carl Davis, Rhys Jones

J Pharm Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe disease during both primary and secondary dengue virus infections in pediatric populations.
Charu Aggarwal, Hasan Ahmed, Pragati Sharma, Elluri Seetharami Reddy, Kaustuv Nayak, Carl W Davis

Nat Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Ebola virus mAb 3A6 with unprecedented potency protects highly viremic animals from fatal outcome and physically lifts its glycoprotein target from the virion membrane.
Erica Saphire, Zhe Li Salie, Zunlong Ke, Peter Halfmann, Lisa Evans DeWald, Carl Davis

Res Sq· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolution and determinants of neutralization of potent head-binding antibodies against Ebola virus.
Xiaoying Yu, Kathryn M Hastie, Carl W Davis, Ruben Diaz Avalos, Dewight Williams

Cell Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Light chain of a public SARS-CoV-2 class-3 antibody modulates neutralization against Omicron.
Anamika Patel, Sanjeev Kumar, Lilin Lai, Meredith Keen, Rajesh Valanparambil, Carl W Davis

Cell Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life of children and young people with anterior chest wall deformity: a systematic review of the literature.
Ashley D Johnstone, Carl Davis, Nicola J Roberts, Kath Sharp

Arch Dis Child· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response.
Anamika Patel, Sanjeev Kumar, Lilin Lai, Chennareddy Chakravarthy, Rajesh Valanparambil, Meredith E Davis-Gardner, Carl W Davis

Structure· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International survey of neuromonitoring and neurodevelopmental outcome in children and adults supported on extracorporeal membrane oxygenation in Europe.
Mirjana Cvetkovic, Giovanni Chiarini, Mirko Belliato, Thijs Delnoij, Paolo Zanatta, Carl Davis

Perfusion· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannulation and decannulation techniques for neonatal ECMO.
Amanda R Jensen, Carl Davis, Brian W Gray

Semin Fetal Neonatal Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent intraocular Ebola virus RNA is associated with severe uveitis in a convalescent rhesus monkey.
Gabriella Worwa, Timothy K Cooper, Steven Yeh, Jessica G Shantha, Amanda M W Hischak, Carl Davis

Commun Biol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody.
Sanjeev Kumar, Anamika Patel, Lilin Lai, Chennareddy Chakravarthy, Rajesh Valanparambil, Meredith E Davis-Gardner, Carl W Davis

Sci Adv· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine models predict rules for updating vaccines against evolving pathogens such as SARS-CoV-2 and influenza in the context of pre-existing immunity.
Rajat Desikan, Susanne L Linderman, Carl Davis, Veronika I Zarnitsyna, Hasan Ahmed

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response.
Anamika Patel, Sanjeev Kumar, Lilin Lai, Chennareddy Chakravarthy, Rajesh Valanparambil, Meredith E Davis-Gardner, Carl W Davis

bioRxiv· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.
Andres Chang, Akil Akhtar, Susanne L Linderman, Lilin Lai, Victor M Orellana-Noia, Carl W Davis

J Clin Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of Virus-Specific Antibody after Depletion of Memory B Cells.
William A Langley, Andreas Wieland, Hasan Ahmed, Mohammed Ata Ur Rasheed, Carl W Davis

J Virol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling suggests that multiple immunizations or infections will reveal the benefits of updating SARS-CoV-2 vaccines.
Rajat Desikan, Susanne L Linderman, Carl Davis, Veronika Zarnitsyna, Hasan Ahmed

bioRxiv· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses.
Jacob C Milligan, Carl W Davis, Xiaoying Yu, Philipp A Ilinykh, Kai Huang

Cell· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis